Lessons from BCG for SARS-CoV-2 vaccine candidates

J Infect Dis. 2020 Nov 30;jiaa637. doi: 10.1093/infdis/jiaa637. Online ahead of print.

Abstract

Developers of SARS-CoV-2 vaccines should consider some of the lessons from a 'new' vaccine introduced in 1921, namely BCG.

Keywords: BCG; COVID-19; SARS-CoV-2; vaccine.